DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for nutritional deficiency disease — screening already-approved drugs against its 33-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleNutritional deficiency disease maps to a 33-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
approvedVitamin AApproved drug
Structures already discussed alongside nutritional deficiency disease in the retrieved literature, rendered from public PubChem SMILES. Which drugs appear here reflects the evidence found, not a ranked prediction.
Molecular view
RETINOL-BINDING PROTEIN (RBP) FROM PIG PLASMA — Vitamin A has a real, experimentally solved structure in complex with this target (PDB 1AQB, 1.65 Å). This is the drug's own deposited structure, not a prediction, and confirms it is a structurally characterised molecule rather than an untested guess.
Loading structure…
helix sheet rtldrag to rotate · scroll to zoom
RCSB Protein Data Bank · entry 1AQB · 1.65 Å · ligand Vitamin A (RTL). Experimental structure, not a prediction.
What the evidence adds up to
A 2021 study of 20 young women three years after hospital treatment for severe restrictive anorexia nervosa found that 60% were recovered or in partial remission. Despite this, 30% still had subnormal body fat and 25% had subnormal skeletal muscle mass. Mean energy intake was 1730 kcal/day, and 80% consumed less than estimated needs. Micronutrient intakes from food were low: 85% had intakes below recommendations for iron, folate, and vitamin D. Serum levels of vitamins A, E, D, and folate were on average adequate, but 20% had subnormal vitamin D (<50 nmol/L). Ferritin levels were significantly lower at follow-up, with 25% below the reference range. Return of menstruation depended on energy intake and body fat.
A 2021 cross-sectional study of 217 patients with chronic kidney disease (112 with pre-dialysis stages 3-5, 33 on haemodialysis, 72 with kidney transplant) found that patients were prescribed an average of nine medications concurrently. The number of prescribed medications was inversely associated with mid-upper arm circumference, triceps skinfold thickness, handgrip strength, serum albumin, and haemoglobin after adjustment for age, sex, and kidney function. Prescription of medications with nausea as a side-effect showed similar associations; prescription of medications with xerostomia as a side-effect was associated with lower handgrip strength.
A 1989 review noted that the incidence of nutritional deficiencies in hospitalised patients is often high, and that indications for nutritional support are controversial and difficult to define. It described three groups: patients with pre-existing weight loss, low plasma albumin, muscle wasting, and peripheral oedema; patients with no overt malnutrition but a history of reduced intake for 2-4 weeks before admission; and patients with normal nutritional status whose underlying pathology will cause malnutrition if support is withheld. A 1954 article observed that classic deficiency diseases such as scurvy, rickets, beriberi, and pellagra are rarely encountered in the United States and readily treated, but that the role of nutrition in patient management has often been neglected because nutritional status was difficult to appraise. A 1942 book on nutritional deficiencies diagnosis and treatment is noted. A 2025 article argues that many conditions believed to be genetic are actually caused by long-term deficiencies in vitamins, minerals, enzymes, and cellular signalling molecules, and that restoring missing micronutrients can normalise conditions previously labelled as genetic.
What is still missing: large prospective trials that track nutritional status and supplementation in defined patient populations, validated biomarkers for subclinical deficiency states, and randomised controlled trials testing whether correcting specific deficiencies reverses clinical phenotypes currently attributed to genetic causes. The 2025 article’s claims about reversing genetic-like conditions lack published clinical data with measurable outcomes.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
Clinical Nutrition · 2021 · 25 citations · open access
Dietary intake and nutritional status in adolescents and young adults with anorexia nervosa: A 3-year follow-up study
AbstractBACKGROUND & AIMS: Patients with anorexia nervosa (AN) restrict their dietary intake leading to malnutrition. Information is scarce on nutrition status during recovery. The aim of the study was to investigate dietary intake, body composition, biochemistry, and status in young women three years after hospital treatment due to severe restrictive AN. METHODS: Dietary intake from four-day food records were compared to a reference group and the Nordic Nutrition Recommendations. Body composition was assessed by dual-energy X-ray absorptiometry (DXA). Serum levels of vitamin A, E, D, folate, and ferritin were assessed. RESULTS: Three years after hospital treatment for AN, 12 subjects (60%) were recovered or in partial remission from AN. Subnormal values of body fat and skeletal muscle mass were present in 30% and 25%. Energy intake was 1730 kcal/day (min-max 705-2441) or 33 kcal/kg/day (16-54). Most (80%) had a total energy intake/day below the estimated needs and 6 (32%) had energy intakes below 1550 kcal/day. Micronutrient intakes from food were low; 16 (85%) had intakes below recommendations of iron, folate, and vitamin D. Serum levels of vitamins A, E, D, and folate were on average adequate; but a subnormal value (<50 nmol/L) of vitamin D was found in 20%. Ferritin levels were significantly lower at follow-up, and 25% had values below reference range. Return of menstruation was dependent of energy intake and body fat. CONCLUSIONS: A regular and careful assessment of nutritional status along with nutritional counseling during recovery is recommended to reduce malnutrition in patients with AN.
Journal of Renal Nutrition · 2021 · 9 citations · open access
Medication Prescription, Common Side-effects, and Nutritional Status are Associated in Patients With Chronic Kidney Disease
AbstractOBJECTIVE: Chronic kidney disease (CKD) is associated with metabolic, nutritional, and extra-renal changes, as well as a high rate of comorbidities, which necessitates the prescription of numerous medications. Patients with CKD often experience poor nutritional status related to disease severity and prescribed medication; however, this association has not been investigated in depth. Therefore, this study aimed at investigating the association between prescribed medication and nutritional status in patients with CKD. METHODS: Assessment of nutritional status was performed using anthropometric and functional measurements and by biochemical measures. Patient history and the number and type of currently prescribed medications were collected from patients' records. We evaluated the total number and the number of specific medicines with common or very common side-effects of nausea or xerostomia. RESULTS: Two hundred seventeen patients with CKD were included in this cross-sectional study (n = 112 with pre-dialysis CKD stages 3-5, n = 33 with hemodialysis, and n = 72 with kidney transplant). On average, patients were prescribed nine medications concurrently. The number of prescribed medications was inversely associated with mid-upper arm circumference, skinfold thickness triceps, handgrip strength, serum albumin, and hemoglobin after adjustment for age, sex, and kidney function. Prescription of medications with nausea as a side-effect showed similar associations, whereas prescription of medications with xerostomia as a side-effect was associated with lower handgrip strength. CONCLUSION: Medication prescription was associated with poor nutritional status in patients with CKD, and monitoring of nutritional status in patients with CKD with long medication lists is warranted to identify and treat patients with poor nutritional status.
Milk Protein and Enteral and Parenteral Feeding in Disease
AbstractThe incidence of nutritional deficiencies in hospitalized patients is often high [20, 21, 62, 90] but the indications for instituting nutritional support are both controversial and difficult to define. In general, patients requiring nutrition support fall into three groups. The first group comprises patients with preexisting weight loss, a low plasma albumin level, muscle wasting, and peripheral edema. Patients in the second group present with no overt malnutrition but have a dietary history of reduced intake for 2–4 weeks preceding admission. Finally, there are patients with normal nutritional status but whose underlying pathology results in malnutrition if nutritional support is withheld. These aspects are discussed in detail elsewhere [115].
New England Journal of Medicine · 1954 · 7 citations
Nutrition in Clinical Medicine
AbstractNUTRITION in clinical medicine has come to have several different connotations depending on whether one is thinking of diagnosis and specific treatment or of patient management. Under the first heading have fallen the "classic" deficiency diseases such as scurvy, rickets, beriberi and pellagra. Indeed, in the minds of many physicians the subject of nutrition has remained identified with these deficiency states, disorders rarely encountered in the United States and today readily treated.On the other hand, the part played by nutrition in patient management has often been neglected, particularly since, in the past, nutritional status was difficult to appraise and . . .
Annals of Internal Medicine · 1942 · 7 citations · open access
Nutritional Deficiencies; Diagnosis and Treatment.
AbstractJournal Article Nutritional Deficiencies: Diagnosis and Treatment Get access Nutritional Deficiencies: Diagnosis and Treatment. By John B. Youmans, A. B., M. SM. D., Associate Professor of Medicine and Director of Post-Graduate Instruction, Vanderbilt University Medical School, Nashville. Assisted by E. White Patton, M. D. Cloth. Price, $5. Pp. 385, with 16 illustrations. Philadelphia, Montreal & London: J. B. Lippincott Company, 1941. Physical Therapy, Volume 22, Issue 3, May 1942, Page 170, https://doi.org/10.1093/ptj/22.3.170c Published: 01 May 1942
AbstractWhy Deficiency-Driven Diseases Mimic Genetic Disorders” explores a groundbreaking scientific perspective: many conditions believed to be genetic are actually caused by long-term deficiencies in essential vitamins, minerals, enzymes, and cellular signaling molecules. These deficiencies affect organ development, blood formation, nerve function, and immune responses in patterns that look exactly like inherited genetic diseases. The article explains how nutritional habits within families create the illusion of heredity, how micronutrient shortages mimic DNA defects, and why cellular dysfunction from deficiencies can be reversed—unlike true genetic mutations. Backed by Natural Immunotherapy (NIT) principles and Cellular Intelligence research, this work challenges the conventional genetic theory and demonstrates how restoring missing micronutrients can completely normalize conditions previously labeled as “genetic.” This article is intended for researchers, clinicians, NIT practitioners, and scholars studying nutrition-based disease models, cellular signaling, and misdiagnosed genetic disorders.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.